[Bone fragility in type 1 diabetes and type 2 diabetes.]

Area of Science:

• Endocrinology
• Metabolic Diseases
• Bone Biology

Background:

• Diabetes mellitus, characterized by hyperglycemia, contributes to microvascular complications and bone metabolism abnormalities.
• Both type 1 and type 2 diabetes are associated with an increased risk of bone fractures.
• Type 1 diabetes often presents with decreased bone mineral density (BMD), while type 2 diabetes may show normal or high BMD but increased fracture risk.

Purpose of the Study:

• To elucidate the distinct mechanisms underlying bone complications in type 1 and type 2 diabetes.
• To investigate the role of insulin deficiency and Insulin-like Growth Factor-1 (IGF-1) in type 1 diabetic bone disease.
• To understand the factors contributing to elevated fracture risk in type 2 diabetes despite potentially normal BMD.

Main Methods:

• Review of existing literature on diabetes, bone metabolism, and fracture risk.
• Analysis of studies comparing bone mineral density and fracture incidence in type 1 and type 2 diabetic patients.
• Examination of the impact of insulin levels and IGF-1 on bone health in diabetic models.

Main Results:

• Type 1 diabetes is associated with reduced BMD and increased fracture risk, linked to insulin deficiency and systemic IGF-1 reduction.
• IGF-1 deficiency plays a critical role in the pathogenesis of reduced BMD in type 1 diabetes.
• Type 2 diabetes patients exhibit an increased fracture risk, primarily attributed to compromised bone quality rather than solely low BMD.

Conclusions:

• Diabetes mellitus significantly impacts bone metabolism, leading to distinct complications in type 1 and type 2 forms.
• Insulin deficiency and subsequent IGF-1 reduction are key drivers of bone loss in type 1 diabetes.
• Bone quality, a critical determinant of bone strength, is a major factor in the elevated fracture risk observed in type 2 diabetes.